Potency710’s Bath Brick: A Spa-Like Experience at Home
Who doesn’t love a long, relaxing soak after a busy day? Now imagine transforming that simple bath into a spa-like
Why the endocannabinoid system belongs in every serious conversation about skin
By Mandy Lile | Licensed aesthetician and founder of POTENCY No. 710
After 30 years in skincare, I am still amazed by what this industry is willing to examine and what it chooses to ignore.
We will study ingredients, devices, peptides, growth factors, delivery systems and increasingly complex biologic technologies. We will talk all day about inflammation, oil production, itching, sensitivity, barrier behavior, recovery and visible aging. Yet mention cannabinoids or even the endocannabinoid system itself, and too many people react as if the conversation has suddenly left science and entered controversy.
That reaction makes no sense to me. I am not talking about smoking. I am talking about skin biology.
The endocannabinoid system is not a trend invented by the beauty industry. It is a biological signaling network already present throughout the body, including the skin. If we are willing to discuss the systems that influence inflammation, sensation, oil production and barrier behavior, then the ECS belongs in that education, not as a miracle story, but as part of the scientific landscape.
The endocannabinoid system, commonly called the ECS, is a network of signaling molecules, receptors and enzymes involved in maintaining balance—what science calls homeostasis. Researchers have identified cannabinoid receptors and related signaling machinery across multiple structures in human skin, including epidermal cells, hair follicles, sebaceous glands, sensory nerves and immune cells.
At its most basic, the system includes endocannabinoids made by the body, receptors that receive or interpret signals, and enzymes that create or break down those signaling molecules. The broader conversation also includes channels and receptors beyond CB1 and CB2, because compounds such as CBD may influence several pathways rather than acting through one simple switch.
This matters because skin is not a passive covering. It is a living, responsive organ constantly communicating with the nervous, immune and endocrine systems while adapting to environmental stress, injury, microbes, temperature and changes in barrier function. A signaling network involved in balance and response is therefore relevant to how we study skin, even when the commercial evidence for a particular finished product remains incomplete.
This does not mean every cannabinoid product works, that every formula is equal or that a cosmetic may claim to diagnose, treat or cure disease. It means something more basic: the biological system is real, it is present in skin and it deserves a place in professional skincare education.
The ECS should not be treated like a fringe idea simply because the cannabis plant has carried decades of cultural and political baggage. Our skin does not organize its biology around stigma. It responds to chemistry, receptors, signaling and formulation.
The word cannabinoid is often treated as if it automatically means marijuana use or getting high. It does not. Cannabinoids are a broad class of compounds. The body makes its own endocannabinoids. Plants produce phytocannabinoids. Researchers can also create compounds that interact with cannabinoid-related pathways.
THC is the phytocannabinoid most associated with intoxication, but it is not the only cannabinoid and it should not be used as shorthand for the entire field. CBD and CBG are non-intoxicating phytocannabinoids being investigated for topical and dermatologic applications. A topical product’s effects also depend on its ingredients, concentration, delivery system, intended use and the quality of the finished formulation, not simply the presence of a cannabis-derived ingredient.
That distinction is essential. We cannot have a serious scientific conversation if one emotionally loaded word is allowed to collapse an entire category of chemistry into a single cultural association.
Research has explored cannabinoid signaling in relation to skin homeostasis, inflammatory responses, itching, sebaceous activity, oxidative stress, wound biology, hair follicle behavior and barrier function. Reviews published across dermatology and pharmacology literature describe meaningful biological potential, but they also make an important limitation clear: much of the available evidence remains preclinical, compound-specific or based on small human studies. Large, well-controlled clinical trials are still limited.
That means two things can be true at once:
The endocannabinoid system is a legitimate part of skin biology and deserves serious study.
The existence of the system does not validate every product claim or establish that every cannabinoid formula produces a clinical result.
That is not a contradiction. It is how responsible science works. We can acknowledge a biological system, follow emerging evidence and remain precise about what has and has not been demonstrated in humans.
When the evidence is early, the appropriate response is not dismissal. It is better research, more transparent formulation and more disciplined language.
An ingredient name on the front of a package tells us very little about how a finished product will perform. Cannabinoids can present formulation challenges involving stability, solubility, oxidation, compatibility and delivery into or across the outer layers of skin. Newer research continues to examine delivery systems intended to improve localized skin delivery, but promising delivery technology is not a substitute for finished-product substantiation.
A responsible evaluation should ask what compound is actually present, how much is present, whether the ingredient has been characterized, how the formula protects its stability, what testing has been performed and whether the claims match the level of evidence.
This is one reason I use the phrase receptor-driven care carefully. It should not mean that one ingredient controls the skin or that every receptor interaction creates a visible result. It means we formulate and educate with an awareness that skin responds through networks of receptors, channels and signaling pathways and that individual response matters.
This is where the inconsistency becomes impossible for me to ignore. Skincare professionals are increasingly comfortable discussing exosomes, conditioned media, stem-cell-derived materials and other biologically sourced technologies. Those conversations should include serious questions about origin, processing, documentation and intended use.
Are the extracellular vesicles or exosome products derived from adult fat or bone marrow, donated umbilical-cord or placental tissue, another human cell line, or an animal or plant source? How was the starting material screened? How was it processed, purified and tested? Can the manufacturer document identity, sterility, quality and consistency?
Those are not attacks on innovation. They are the questions responsible professionals should ask whenever a biologically derived product is placed on, or introduced through the skin. The FDA has warned that there are currently no FDA-approved exosome products and has raised concerns about unapproved products marketed to prevent, treat or cure diseases or conditions.
Yet somehow a well-characterized, plant-derived cannabinoid can trigger more fear than a product made from cultured human or animal cells. That is not a consistent standard. That is stigma deciding which science feels acceptable.
The answer is not to lower the bar for cannabinoids. It is to apply the same bar to everything.
Science should not depend on whether someone feels personally ‘open’ to a subject. The better questions are:
That is the standard I want for cannabinoid skincare. Not blind acceptance. Not exaggerated promises. Not fear. Curiosity, transparency and evidence.
If this category is going to mature, brands and professionals must move beyond both stigma and hype. Responsible cannabinoid skincare should be built around a few non-negotiables:
Clear ingredient identity. ‘Hemp’ is not a complete description. The consumer and professional should be able to understand which extract or isolated compound is being used.
Appropriate testing.
Raw-material documentation matters, but the finished formula should also be evaluated for quality, stability and safety as appropriate to its use.
Accurate language.
Cosmetic benefits should be described without borrowing the certainty or terminology of disease treatment.
Formulation transparency.
Concentration alone does not tell the whole story, but neither should it be hidden behind vague marketing.
Respect for individual response.
Skin condition, barrier status, sensitivities, other products and the overall formula can all influence experience.
Education without intoxication fearmongering.
Consumers deserve to understand the difference between cannabinoids, routes of use and realistic topical expectations.
The category does not need louder promises. It needs better questions and better standards.
For three decades, I have watched the industry rename the same goals: calm the appearance of stressed skin, support the barrier, improve comfort, balance oil, protect against environmental stress and help skin recover. We keep adding products and technologies to address those outcomes, but rarely teach the signaling network that may connect many of these conversations.
The endocannabinoid system brings the conversation home because it asks us to stop looking only at isolated ingredients and start looking at communication within the skin. It invites better questions about balance, receptors, formulation and individual response.
The future of skincare will not be built by refusing to examine a biological system because one group of plant compounds associated with it makes people uncomfortable. It will be built by professionals willing to separate cannabis stigma from cannabinoid science and marketing excitement from evidence.
We do not need less scrutiny. We need equal scrutiny and a more complete understanding of the skin.
The endocannabinoid system is not the entire story of skin. But it is undeniably part of the story. It is time our industry learned how to talk about it.
Does human skin really have an endocannabinoid system?
Researchers have identified cannabinoid receptors, endocannabinoids and related enzymes and signaling machinery in human skin structures. The exact role of this network varies by cell type and biological context, and research is ongoing.
Will topical CBD make someone feel high?
CBD is non-intoxicating. A cosmetic topical containing CBD is not the same as inhaling or ingesting THC. Product composition and quality still matter, and consumers should review the ingredient list and manufacturer information.
Does the presence of CBD mean a skincare product works?
No. An ingredient’s presence does not establish the performance of a finished product. Concentration, formulation, stability, delivery, supporting ingredients, testing and the individual user’s skin all matter.
Are cannabinoid skincare products FDA-approved?
Cosmetics are not generally preapproved by the FDA in the same way as drugs. A cosmetic may support appearance-related benefits, but claims to diagnose, treat, cure or prevent disease can cause the product to be regulated as a drug. Consumers and professionals should be cautious of disease-treatment claims that are not supported by an approved drug pathway.
Is the science settled?
No—and that is precisely why the subject belongs in serious education. The ECS in skin is well established as a field of biological research, while evidence for specific topical compounds, formulations and clinical outcomes is still developing.
About the author
Mandy Lile is a licensed aesthetician with approximately 30 years of experience and the founder of POTENCY No. 710, a topical cannabinoid skincare company focused on ingredient awareness, skin biology and receptor-driven care.
Who doesn’t love a long, relaxing soak after a busy day? Now imagine transforming that simple bath into a spa-like
Potency No. 710 embraces nature and self-care, combining the two into an easy-to-adopt regimen. The exquisite line of products offered
In the world of skincare, we often focus on topical treatments and external factors. However, true beauty radiates from within,
Have you ever wondered why your forehead seems to shine like a beacon by midday, while your cheeks remain relatively
There was a time when a bathroom counter looked like a laboratory mid experiment. Cleanser. Toner. Essence. Hydration mist. Serum.
Your skin isn’t just a surface; it’s a thriving ecosystem. Every pore, follicle, and layer is home to millions of
